Friday, 24 March 2017

Xenon Pharmaceuticals' acne drug fails mid-stage study

(Reuters) - Xenon Pharmaceuticals Inc said on Friday its drug to treat moderate to severe facial acne failed to meet the primary goal in a mid-stage study.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)